A. Harstrick

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

David Cunningham, Yves Humblet, Salvatore Siena et al. · New England Journal of Medicine · 2004 · 5K citations · Full text

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

José Baselga, José Trigo, Jean Bourhis et al. · Journal of Clinical Oncology · 2005 · 491 citations

Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

Wilfried Eberhardt, H. Wilke, Georgios Stamatis et al. · Journal of Clinical Oncology · 1998 · 330 citations

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

U. Vanhoefer, Mitra Tewes, Federico Rojo et al. · Journal of Clinical Oncology · 2003 · 259 citations

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.

Christian Kollmannsberger, J. Beyer, Jean‐Pierre Droz et al. · Journal of Clinical Oncology · 1998 · 204 citations